Clinical Research
corporate_fare

Daiichi Sankyo Europe GmbH

Address
Zielstattstrasse 48, Thalk.Obersendl.-Forsten-Fuerstenr.-Solln

Sponsor Overview

assignment
5
sponsored trials
science
4
molecules
location_city
13
research centres
public
4
countries
person_search
13
investigators

Specializations

Cardiovascular Risk Management

Research activity centers on lipid-lowering therapy and cardiovascular prevention, with attention to treatment combinations used in managing elevated cholesterol and broader atherosclerotic risk.

  • Statin-based therapy
  • Cholesterol absorption inhibition
  • Combined lipid-modifying regimens

The sponsor’s clinical research includes fixed-dose combinations involving bempedoic acid, ezetimibe, and atorvastatin or rosuvastatin, reflecting a focus on therapies used in hyperlipidaemia management.

Fixed-Dose Combination Medicines

Clinical interest extends to combination formulations designed to simplify treatment with multiple cardiometabolic agents in a single tablet.

  • Bempedoic acid and ezetimibe combinations
  • Single-tablet co-formulations
  • Tablet-to-tablet bioequivalence

These studies examine how fixed-dose products compare with separately administered tablets, supporting development in oral combination therapy for lipid control.

Pharmacokinetic Equivalence Assessment

The sponsor’s portfolio includes work in bioequivalence and comparative exposure assessment for oral small-molecule medicines.

  • Relative bioavailability
  • Oral formulation comparison
  • Therapeutic interchangeability

This area supports evaluation of whether fixed-dose combinations deliver comparable systemic exposure to individual components, a key issue in regulatory development for cardiovascular medicines.

Oral Lipid-Lowering Treatment Development

Research is directed toward oral therapies intended for long-term use in patients requiring LDL-cholesterol reduction and related metabolic management.

  • HMG-CoA reductase inhibition
  • Cholesterol synthesis modulation
  • Adjunctive lipid therapy

The funded studies align with development of cardiovascular medicines that combine established and newer lipid-modifying mechanisms in a single treatment option.

Sponsored Trials

Trial Name Country Status
Bioequivalence Study of a Fixed-Dose Combination of Bempedoic Acid, Ezetimibe, and Atorvastatin Versus Individual Tablet FormulationsPortugal PortugalNot Recruiting
Bioequivalence Study of Fixed Dose Combination of Bempedoic Acid, Ezetimibe, and Rosuvastatin in Healthy SubjectsPortugal PortugalNot Recruiting
Bioequivalence Study of Fixed-Dose Combination of Bempedoic Acid, Ezetimibe, and Atorvastatin Versus Individual Tablets in Healthy SubjectsPortugal PortugalNot Recruiting
Bioequivalence Study of Fixed-Dose Combination of Bempedoic Acid, Ezetimibe, and Rosuvastatin Versus Individual Tablets in Healthy SubjectsPortugal PortugalNot Recruiting
Effect of bempedoic acid/ezetimibe plus high‑intensity statin therapy on plaque regression in coronary atherosclerosis patients without prior CV eventsGermany GermanyItaly ItalySpain SpainRecruiting

Data & Insights

science
Molecule Portfolio
Compounds under investigation
0
Exclusive Molecules
out of 4 total (0% not shared with other sponsors)

This sponsor works with 4 molecules, of which 0 are not being studied by other sponsors.

hub
Site Partnerships
Collaboration with research centres
8%
Return partnership rate
1 of 13 sites collaborated multiple times

This sponsor has worked with 13 sites across their trial portfolio.

Therapeutic Focus

  • 1.
    Not possible to specify4 trials
    220 other sponsors
  • 2.
    Cardiovascular Diseases1 trial
    359 other sponsors

Partnered Research Centres

13 centres
location_city
assignment560
Azienda Ospedaliera Universitaria Federico II Di Napoli
Address
Via Sergio Pansini 5, 80131 Naples
Learn morearrow_forward
location_city
assignment87
Blueclinical Investigacao E Desenvolvimento Em Saude Lda.
Address
Hospital Da Prelada 0 Floor And 3 rd Floor, Rua Sarmento De Beires 153, 4250-449 Porto
Learn morearrow_forward
location_city
assignment518
Center For Pediatric And Adolescent Medicine Of The Johannes Gutenberg University Mainz
Address
Langenbeckstrasse 1, Oberstadt, 55131 Mainz
Learn morearrow_forward
location_city
assignment1047
Charite Universitaetsmedizin Berlin KöR
Address
Hindenburgdamm 30, Lichterfelde, 12203 Berlin
Learn morearrow_forward
location_city
assignment1
El Hospital Universitario San Rafael de Madrid
Address
Calle De Serrano 199, 28016 Madrid
Learn morearrow_forward
location_city
assignment150
Hospital Quironsalud Barcelona
Address
Placa D'alfonso Comin 5-7, 08023 Barcelona
Learn morearrow_forward
Page 1 of 3

Want to get in touch with this sponsor?

Send a question and we'll pass it on to Daiichi Sankyo Europe GmbH.

Need a custom report on this sponsor?

Competitive positioning, market entry, partnership opportunities — tell us the question.

Is something out of date?

Tell us what needs correcting and we'll update this profile.